Search

Your search keyword '"Tellurium administration & dosage"' showing total 51 results

Search Constraints

Start Over You searched for: Descriptor "Tellurium administration & dosage" Remove constraint Descriptor: "Tellurium administration & dosage"
51 results on '"Tellurium administration & dosage"'

Search Results

1. "Golgi-customized Trojan horse" nanodiamonds impair GLUT1 plasma membrane localization and inhibit tumor glycolysis.

2. Bioaccessibility as a determining factor in the bioavailability and toxicokinetics of cadmium compounds.

3. Gut microbiota and lipid metabolism alterations in mice induced by oral cadmium telluride quantum dots.

4. Biodistribution and Systemic Effects in Mice Following Intravenous Administration of Cadmium Telluride Quantum Dot Nanoparticles.

5. Cytotoxicity studies of quantum dots with the electroporation method.

6. Evaluation of Quantum Dot Skin Penetration in Porcine Skin: Effect of Age and Anatomical Site of Topical Application.

7. Tellurium epigenetic transgenerational effects on behavioral expression of coping behavior in rats.

8. Synthesis, characterization and in vivo evaluation of cadmium telluride quantum dots toxicity in mice by toxicometabolomics approach.

9. The role of unfolded protein response and ER-phagy in quantum dots-induced nephrotoxicity: an in vitro and in vivo study.

10. Detecting Triple-Vessel Disease with Cadmium Zinc Telluride-Based Single-Photon Emission Computed Tomography Using the Intensity Signal-to-Noise Ratio between Rest and Stress Studies.

11. Dose and time effect of CdTe quantum dots on antioxidant capacities of the liver and kidneys in mice.

12. Single-scan rest/stress imaging with 99mTc-Sestamibi and cadmium zinc telluride-based SPECT for hyperemic flow quantification: A feasibility study evaluated with cardiac magnetic resonance imaging.

13. Cadmium Telluride Quantum Dots as a Fluorescence Marker for Adipose Tissue Grafts.

14. Multifunctional Cu 2-x Te Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453.

15. Feasibility of ultra low-dose thallium stress-redistribution protocol including prone imaging in obese patients using CZT camera.

16. REPEATED EXPOSURE OF SODIUM TELLURITE ON THE RAT LIVER AND ON THE POTENTIAL MECHANISMS OF THE METALLOID-INDUCED HEPATOTOXICITY.

17. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.

18. Facile synthesis of CdTe@GdS fluorescent-magnetic nanoparticles for tumor-targeted dual-modal imaging.

19. Threshold Dose of Three Types of Quantum Dots (QDs) Induces Oxidative Stress Triggers DNA Damage and Apoptosis in Mouse Fibroblast L929 Cells.

20. Toxicity assessment of repeated intravenous injections of arginine-glycine-aspartic acid peptide conjugated CdSeTe/ZnS quantum dots in mice.

21. Intracellular diagnostics: hunting for the mode of action of redox-modulating selenium compounds in selected model systems.

22. Degradation of aqueous synthesized CdTe/ZnS quantum dots in mice: differential blood kinetics and biodistribution of cadmium and tellurium.

23. New strategy of efficient inhibition of cancer cells by carborane carboxylic acid-CdTe nanocomposites.

24. The effect of nanoparticles in rats during critical periods of pregnancy.

25. Metalloestrogenic effects of quantum dots.

26. Quantum dots affect expression of CD133 surface antigen in melanoma cells.

27. Reconstruction of radiation doses in a case-control study of thyroid cancer following the Chernobyl accident.

28. Hemolytic and genotoxic evaluation of organochalcogens in human blood cells in vitro.

29. In vitro and in vivo toxicity of CdTe nanoparticles.

30. Tellurium-induced dose-dependent impairment of antioxidant status: differential effects in cerebrum, cerebellum, and brainstem of mice.

31. Dose- and duration-dependent alterations by tellurium on lipid levels: differential effects in cerebrum, cerebellum, and brain stem of mice.

32. Biokinetics of radiotellurium in rats.

33. Tellurium causes dose-dependent coordinate down-regulation of myelin gene expression.

34. Biochemistry of tellurium.

35. Influence of the administered mass of tellurium on plasma clearance in rabbits.

36. Acute pulmonary toxicity of copper gallium diselenide, copper indium diselenide, and cadmium telluride intratracheally instilled into rats.

37. [Experimental study of sensitizing effects of alkyl compounds of tellurium and tin].

38. The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent.

39. Tellurium blocks cholesterol synthesis by inhibiting squalene metabolism: preferential vulnerability to this metabolic block leads to peripheral nervous system demyelination.

40. Renal excretion of tellurium after peroral administration of tellurium in different forms to healthy human volunteers.

41. Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms.

42. Lipid droplets in Schwann cells during tellurium neuropathy are derived from newly synthesized lipid.

43. Myocardial ultrastructural alterations in ducklings fed tellurium.

44. Amounts of twelve elements required to induce selenium-vitamin E deficiency in ducklings.

46. [The influence of tellurium upon experimental dental caries development in the rat. Effect of cysteine, thioctic acid or ascorbic acid combinations on nutrition and experimental dental caries development induced by sodium tellurate].

47. Tellurium and tellurium dioxide: single endotracheal injection to rats.

48. Protein binding of tellurium-127m by maternal and fetal tissues of the rat.

50. The metabolism of tellurium in rats.

Catalog

Books, media, physical & digital resources